Regional blood flow, capillary permeability, and compartmental volumes: Measurement with dynamic CT - Initial experience

Radiology

Volumn 210, Issue 1, 1999, Pages 269-276

  Brix, Gunnar ^a,b   Bahner, Malte L ^a   Hoffman, Ulf ^a   Horvath, Andrea ^a   Schreiber, Wolfgang ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b Institut fur Strahlenhygiene   (Germany)

Author keywords

Blood, flow dynamics; Computed tomography (CT), contrast enhancement; Computed tomography (CT), diffusion study; Head and neck neoplasms

Indexed keywords

ADULT; ARTICLE; CAPILLARY PERMEABILITY; CAPILLARY WALL; CLINICAL ARTICLE; COMPARTMENT MODEL; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; HEAD AND NECK CARCINOMA; HUMAN; IMAGE PROCESSING; MALE; OROPHARYNX CARCINOMA; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA;

EID: 0032900885     PISSN: 00338419     EISSN: None     Source Type: Journal    
DOI: 10.1148/radiology.210.1.r99ja46269     Document Type: Article

References (57)

1. Axel L. Cerebral blood flow determination by rapid-sequence computed tomography. Radiology 1980; 137:679-686.
2. Berninger WH, Axel L, Norman D, Napel S, Redington RW. Functional imaging of the brain using computed tomography. Radiology 1981; 138:711-716.
3. Norman D, Axel L, Berninger WJ, et al. Dynamic computed tomography of the brain: techniques, data analysis and applications. AJR 1981, 136:759-770.
4. Hopper JL, Davis SD, Tress BM, Kaye AH, Rossiter SC, Derrick PL. Analysis of dynamic computed tomography scan brain images. Invest Radiol 1987; 22:651-657.
5. Nambu K, Takehara R, Terada T. A method of regional cerebral blood perfusion measurement using dynamic CT with an iodinated contrast medium. Acta Neurol Scand 1996; 166:(suppl)28-31.
6. Rosen BR, Belliveau JW, Chien D. Perfusion imaging by nuclear magnetic resonance. Magn Reson Q 1989; 5:263-281.
7. Rempp K, Brix G, Wenz F, Becker C, Gückel F, Lorenz WJ. Quantitative assessment of cerebral blood flow and volume by dynamic susceptibility enhanced MR imaging. Radiology 1994; 193:637-641.
8. Ostergaard L, Weiskoff RM, Chesler DA, Gyldensted C, Rosen BR. High resolution measurements of cerebral blood flow using intravascular tracer bolus passages. 1. Mathematical approach and statistical analysis. Magn Reson Med 1996; 36:715-725.
9. Schreiber W, Gückel F, Stritzke P, Schmiedek P, Schwarz A, Brix G. Cerebral blood flow and cerebrovascular reserve capacity: absolute quantification by dynamic magnetic resonance imaging. J Cereb Blood Flow Metab 1998; 18:1143-1156.
10. Miles KA. Measurement of tissue perfusion by dynamic computed tomography. Br J Radiol 1991; 64:409-412.
11. Peters AM, Gunasekera RD, Henderson BL, et al. Non-invasive measurements of blood flow and extraction fraction. Nucl Med Commun 1987; 8:823-837.
12. Blomley MJK, Coulden R, Bufkin C, Lipton MJ, Dawson P. Contrast bolus dynamic computed tomography for the measurement of solid organ perfusion. Invest Radiol 1993; 28(suppl):S72-S77.
13. Miles KA, Hayball MP, Dixon AK. Functional images of hepatic perfusion obtained with dynamic CT. Radiology 1993; 188:405-411.
14. Miles KA, Hayball MP, Dixon AK. Measurement of human pancreatic perfusion using dynamic computed tomography with perfusion imaging. Br J Radiol 1995; 68:471-475.
15. Jain RK. Determinants of tumor blood flow: a review. Cancer Res 1988; 48:2641-2658.
16. Jain RK. Transport of molecules across tumor vasculature. Cancer Metastasis Rev 1987; 6:559-593.
17. Jain RK. Transport of molecules in the tumor interstitium: a review. Cancer Res 1987; 47: 3039-3051.
18. Kalender W, Schmidt B, Zanki M, Schmidt M. A PC program for estimating dose and effective dose values in computed tomography. Eur Radiol (in press).
19. Crosbie RE, Hayes W. Variable-step integration methods for simulation applications. Appl Math Modeling 1976; 1:137-140.
20. Sparks LE. Variable step size Runge-Kutta technique for solving initial value problems. Access 1983; Jan/Feb:30-34.
21. Gaehtgens P. Physiologie des lutes. In: Deetjem P, Speckmann EJ, eds. Physiologie. Munich, Germany: Urban & Schwarzenberg, 1992; 261-290.
22. Cooper KE, Edholm OG, Mottram RF. The blood flow in skin and muscle of the human forearm. J Physiol 1955, 128:258-268.
23. Weber F, Anlauf M, Serdarevic M. Noninvasive, quantitative determination of muscle blood flow in man by a combination of venous-occlusion plethysmography and computed tomography. Basic Res Cardiol 1988; 83:327-341.
24. Burchert W, Schellong S, van den Hoff J, Meyer GJ, Alexander K, Hundeshagen H. Oxygen-15-water PET assessment of muscular blood flow in peripheral vascular disease. J Nucl Med 1996; 37:93-98.
25. Ruotsalainen U, Raitakari M, Nuutila P, et al. Quantitative blood flow measurement of skeletal muscle using oxygen-15-water and PET. J Nucl Med 1997; 38:314-319.
26. 2 steady-state and labeled microspheres. J. Nucl Med 1983; 24:1135-1142.
27. Senda M, Fischman AJ, Weise S, et al. Regional perfusion, oxygen metabolism, blood volume and immunoglobulin G accumulation at focal sites of infection in rabbits. Eur J Nucl Med 1992; 19:166-172.
28. Sachs L. Angewandte statistik. 7th ed. Berlin, Germany: Springer-Verlag, 1992; 338.
29. Tofts PA, Kermode AG. Measurement of the blood-brain barrier permeability and leakage space using dynamic MR imaging. I. Fundamental concepts. Magn Reson Med 1991; 17:357-367.
30. Tofts PS, Berkowitz B, Schnall MD. Quantitative analysis of dynamic Gd-DTPA enhancement in breast tumors using a permeability model. Magn Reson Med 1995; 33:564-568.
31. Brix G, Semmler W, Port R, Schad LR, Layer G, Lorenz WJ. Pharmacokinetic parameters in CNS Gd-DTPA enhanced MR imaging. J Comput Assist Tomogr 1991; 15:621-628.
32. Hoffmann U, Brix G, Knopp MV, Hess T, Lorenz WJ. Pharmacokinetic mapping of the breast: a new method for dynamic MR mammography. Magn Reson Med 1995; 33:506-514.
33. Pugh ND, Hutcheson IR, Edwards DH, Nossen JO, Karlsson JO, Griffith TM. Angiographic contrast media relax isolated rabbit aorta through an endothelium-independent mechanism that may not depend on the presence of the iodine atom. Br J Radiol 1995; 68:23-26.
34. Szolar DH, Saeed M, Flueckiger F, et al. Effects of iopromide on vasoactive peptides and allergy-mediated substances in healthy volunteers. Invest Radiol 1995; 30:144-149.
35. O'Connor SW, Bale WF. Accessibility of circulating immunoglobulin G to the extravascular compartments of solid rat tumors. Cancer Res 1984; 44:3719-3723.
36. Gullino PM, Grantham FH, Smith SH. The interstitial water space of tumors. Cancer Res 1965; 25:727-731.
37. Vaupel P, Schlenger K, Hoeckel M. Blood flow and tissue oxygenation of human tumors: an update. Adv Exp Med Biol 1992; 317:139-151.
38. Wheeler RH, Ziessman HA, Medvec BR, et al. Tumor blood flow and systemic shunting in patients receiving intraarterial chemotherapy for head and neck cancer. Cancer Res 1986, 46:4200-1204.
39. Hermans R, Lambin P, van den Bogaert W, Haustermans K, Van der Goten A, Baert AL. Non-invasive tumor perfusion measurement by dynamic CT: preliminary results. Radiother Oncol 1997, 44:159-162.
40. Jain RK. Mass and heat transfer in tumors. Adv Transport Proc 1984; 3:205-339.
41. Gerlowski LE, Jain RK. Microvascular permeability of normal and neoplastic tissues. Microvasc Res 1986; 31:288-305.
42. Vaupel P. Physiological properties of malignant tumours. NMR Biomedicine 1992; 5: 220-225.
43. Folkman J. Tumor angiogenesis. Adv Cancer Res 1985; 43:175-203.
44. Folkman J. What is the evidence that tumors are angiogenesis dependent? J Natl Cancer Inst 1990; 82:4-6.
45. Folkman J. Intratumoral microvessel density as a prognostic factor in cancer. Am J Pathol 1995; 147:9-19.
46. Vaupel P, Kallinowski F, Okunieff P. Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors. Cancer Res 1989; 49:6449-6465.
47. Weidner N, Joseph PS, William RW, Folkman J. Tumor angiogenesis and metastases: correlation in invasive breast carcinoma. N Engl J Med 1991; 324:1-8.
48. Toi M, Kashitani J, Tominaga T. Tumor angiogenesis is an independent prognostic indicator in primary breast cancer. Int J Cancer 1993; 55:371-374.
49. Hayes DF. Angiogenesis and breast cancer. Hematol Oncol Clin North Am 1994; 8:51-71.
50. Knopp MV, Brix G, Junkermann HJ, Sinn HP. MR mammography with pharmacokinetic mapping for monitoring of breast cancer treatment during neoadjuvant therapy. Magn Reson Imaging Clin N Am 1994; 2:633-658.
51. Hawighorst H, Knapstein PG, Weikel W, et al. Angiogenesis of uterine cervical carcinoma: characterization by pharmacokinetic magnetic resonance parameters and histological microvessel density with correlation to lymphatic involvement. Cancer Res 1997; 457:4777-4786.
52. Overgaard J. Importance of tumor hypoxia in radiotherapy: a metaanalysis of controlled clinical trials. (abstr). Radiother Oncol 1992; 24(suppl):S64.
53. Horvath AS, Schreiber WG, Hoffmann U, Knopp MV, Hawighorst H, Brix G. A pharmacokinetic model for quantification of the perfusion rate and capillary permeability from dynamic T1-weighted MRI (abstr). In: Proceedings of the Sixth meeting of the International Society for Magnetic Resonance in Medicine. Berkeley, Calif: International Society for Magnetic Resonance in Medicine, 1998; 178.
54. Roberts TPL. Physiologic measurements by contrast-enhanced MR imaging: expectations and limitations. JMRI 1997; 7:82-90.
55. Gjedde A. Tracer kinetics. In: Wagner H, Szabo Z, Buchanan JW, eds. Principles of nuclear medicine. Philadelphia, Pa: Saunders, 1995; 451-461.
56. Kety SS. The theory and applications of the exchange of inert gas at the lungs and tissues. Pharmacol Rev 1951; 3:1-41.
57. Morales MF, Smith RE. On the theory of blood-tissue exchange of inert gases. VI. Validity of approximate uptake expressions. Bull Math Biophys 1948; 10:191-200.